medicament Budikson Nab contains the powerful not halogenated GKS - budesonid, intended for treatment of bronchial asthma at patients for whom application of inhalers with spraying of medicines compressed air or in the form of a dosage form of dry powder is inefficient or inexpedient.

for application to babies and children, patients of grain (complications of a sharp viral upper respiratory tract infection, also known as a laryngotracheobronchitis or subcopular laryngitis) that is the indication for hospitalization.

for treatment of exacerbation of a chronic obstructive disease of easy (HOBL) in case application of a budesonid in the form of suspension for dispersion is recognized reasonable.

for simplification of bad attacks of asthma or asthmatic states and an apnoea.

Structure

active ingredient: budesonid;

1 ml of suspension;

excipients: sodium edetat, sodium chloride, twin-80, citric acid, sodium citrate, water for injections.

Contraindication

Hypersensitivity to a budesonid or to any other component of medicine.

Route of administration

Budikson Nab Suspension for dispersion should be used by means of the nebulizer with the adapter or a respiratory mask.

for the purpose of minimization of risk of developing of candidiasis in a mouth and a throat the patient has to rinse a mouth water after each inhalation.

to the Patient also should advise to wash surely a face with water after use

nebulizer with a respiratory mask for prevention of irritation of the person.

should not use ultrasonic nebulizers as they do not provide corresponding dosing of a budesonid.

Nebulizer and the compressor have to make drops with a diameter from 3 to 5 mm.

Feature of application

Pregnant

Introduction of a budesonid during pregnancy demands careful weighing of advantage for the woman in comparison with risk for a fruit. Inhalation glucocorticosteroids it is necessary to give preference before oral GKS considering smaller expressiveness of system effects at application in the doses necessary for achievement identical the answer from respiratory organs.

Children

to children according to indications (see Sections of "Indication" and "Features of Application").

Drivers

Means Budikson Nab does not affect ability to steer vehicles and to work with other mechanisms.

Overdose

Acute overdose of means Budikson Nab should not make clinically significant problem even at application of overdoses.

Drug contains 0.1 mg/ml of sodium edetat that as it is proved, causes narrowing of bronchial tubes if its level exceeds 1.2 mg/ml.

Side reactions

Infection and invasion. Often. Stomatopharynx candidiasis pneumonia (at patients with HOBL).

Respiratory, thoracic and mediastinal violations. Often. cough, hoarseness; irritation of a throat; dysphonia.

Interaction

At women who at the same time accepted estrogen or hormonal contraceptives the concentration of a budesonid in blood plasma increased and the effect of GKS amplified, however at application of a budesonid together with low doses of the combined oral contraceptives this effect was absent.

Because of possible oppression of function of adrenal glands the test with stimulation of AKTG for diagnostics of hypophysial insufficiency can yield wrong results (low values).

to Store

at a temperature below 30 °C out of children's reach. Not to freeze. To store in original packing and an envelope for protection against light.

Expiration date. 36 months.

After opening of an envelope the containers, contain in it, it is necessary to use within 3 months. After restoration or cultivation, suspension needs to be used within 30 minutes.